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Summary All cases of Hodgkin's disease (HD) notified to the Danish Cancer Registry from 1976 through
1987 in patients less than 70 years old were reviewed in order to identify patients in whom a correct diagnosis
was established only post mortem. The case records of such patients were reviewed in a search for clinical
features that could have ensured a correct pre mortem diagnosis.
HD was diagnosed after death in 31 patients in this unselected population based study and thus constituting
only 2.4% of all patients less than 70 years with HD, but 14.1% of the group aged 65-69 years. Most patients
were identified during the first part of the study period, which may reflect a decreasing autopsy rate. HD was
considered to be a coincidental finding in four patients and the primary cause of death in 27 patients. Among
the later 27 patients a number of unfavourable prognostic factors were a common finding: persistent
unex-plained fever and weight loss, pencytopenia, hepatic involvement, bone marrow involvement, advanced
stage disease, and lymphocytic depletion histology. However, most of the patients had no concurrent diseases
and may have benefitted from a correct diagnosis and a potentially curative treatment.
The many uncommon features of HD together with the frequent findings of falsely negative chest X-ray,
bone marrow examination, liver biopsy, and ultrasound contributed to the difficulty in diagnosis. In about 1/3
of the patients clinical findings suggestive of lymphoma did not result in relevant diagnostic procedures.
The evolution of management strategies for Hodgkin's
disease (HD) during the past three decades has served as a
model for the development of effective cancer treatment pro-
grams. With contemporary treatment 65 to 80% of all
patients with HD will achieve a sustained complete remission
(Nordentoft et al., 1980; DeVita et al., 1990).
The clinical stage and especially the tumour burden at
presentation remain among the strongest prognostic factors
(Hagemeister, 1988; Specht et al., 1988). An early diagnosis
is, therefore, essential. The most common presentation of
HD is peripheral adenopathy (Ultmann et al., 1966) but a
diversity of other clinical features may be prominent which
may result in a delayed diagnosis. In a study of 359 patients
aged 40 to 79 years the time span between initial symptoms
and diagnosis was about 20 weeks (Guinee et al., 1991).
Cases have been reported of patients who died of HD but
in whom the correct diagnosis was established only at
autopsy (Korman et al., 1979; Lefkowitch et al., 1985;
Sobrinho-Simoes et al., 1983; Trewby et al., 1979). Such
patients are deprived of a potentially curative treatment.
We have reviewed a national based group of patients with
HD to identify cases diagnosed post mortem. It was the
purpose of the study to quantify this group of patients in a
population based setting and to search for clinical features
that could have resulted in an earlier diagnosis.
During the 12-year period from January 1, 1976 through
December 31, 1987 a total of 1283 new cases of HD in
patients resident in Denmark, and aged less than 70 years at
the time of diagnosis were notified. The age distribution in
5-year age groups is shown in Figure 1.
For each case a date of diagnosis is registered in the
Cancer Registry. This may be the accurate date of diagnosis
or the date of the hospital admission that led to the diag-
nosis. In order to identify all patients in whom the diagnosis
of HD was not established before death, we reviewed all
cases in whom the period from the registered date of diag-
nosis to the date of death was less than 3 months.
The relevant case records from the clinical and
pathological departments were reviewed. Characteristics con-
cerning symptoms, clinical course, laboratory, and pathology
findings were recorded. When serial measurements of
laboratory data were performed the most abnormal value
was recorded.
In 66 patients the period from the registered date of diag-
nosis to the date of death was less than 3 months. The case
records of three patients could not be retrieved. A review of
the available 63 case records revealed that in 32 patients the
diagnosis of HD was known at the time of death. Accord-
ingly, the study group consists of the remaining 31 patients in
whom the diagnosis of HD was established after death.
Material and methods
The Danish Cancer Registry has since 1943 received
notifications of malignant diseases from all clinical and
pathological departments in the country. The notifications to
the registry is supplemented by a scrutiny of all death
certificates. The registry's coverage of cancer occurrence in
Denmark is virtually complete (Storm, 1988).
This study was limited to persons less than 70 years old at
the time of diagnosis because the prognosis of Hodgkin's
disease in persons aged 70 and more is very poor (Nordentoft
et al., 1980), and the autopsy rate is significantly lower in








Figurel Incidence of Hodgkin's disease in Denmark 1976-1987
from 0 to 70 years of age. Presented in 5-year age groups.
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Results
Occurrence
The age distribution of the patients in whom the diagnosis of
HD was established after death is shown in Figure 2. The
youngest patient was 53 years old at the time of death. The
number of unrecognised HD cases increased significantly
with increasing age. The study group constituted 2.4% of all
patients less than 70 years diagnosed during the same period,
but 14.1% of the group aged 65-69 years. Twenty of the 31
patients were male. A similar male preponderance was found
among the total group of HD patients. The majority of the
cases (22 out of 31) occurred during the first half of the study
period.
Four patients died of causes unrelated to HD. No HD
related symptoms had been observed prior to death, and the
autopsy disclosed only minor tumour burden corresponding
to stage IA or IIIA. Theses cases are considered truly coin-
cidential findings and will not be discussed in further details.
The rest of the paper deals with the 27 patients in whom
symptomatic but unrecognised HD was the only or the major
cause of death.
Clinical data
Fifteen patients were seen in departments of internal
medicine, four patients in departments of surgery, five
patients in both types of departments, and four patients were
also or exclusively seen in specialised departments of
oncology or haematology.
Clinical data of the patients are summarised in Table I.
Unexplained prolonged fever was experienced during a
median time of 40 days (range 12-230) by 18 patients.
Peripheral lymphadenopathy was noted in nine patients,
but resulted in biopsy in only two cases. In one patient an
inguinal lymph node biopsy showed chronic lymphadenitis
and in the other patient a supraclavicular lymph node biopsy
was interpreted as metastatic anaplastic carcinoma.
Hepatomegaly was noted in 15 patients. Autopsy demon-
strated hepatic involvement in ten of these cases. Liver
biopsy was performed in five patients, who were all proven
later to have hepatic involvement. In one patient the biopsy
showed HD, but the patient died before the result of the
microscopic study was available. None of the hepatic biopsies
in the remaining four patients showed HD. However,
granuloma formation was noted in three of the cases.
Splenomegaly was diagnosed in seven patients and autopsy
demonstrated splenic involvement in all cases.
Laparotomy was performed in three patients. In one
patient cholecystitis was suspected and freeze microscopy was
suggestive of carcinoma; the patient died the day following
surgery. In another patient a colon tumour was suspected
and freeze microscopy was suggestive of lymphoma. How-
ever, the biopsy was later reinterpreted as carcinoma. The







Table I Symptoms and clinical findings in the 27 patients who died
of unrecognised Hodgkin's disease
Number %
Prolonged fever 18 67
Weight loss 18 67
Night sweats 5 19
Pruritus 2 7
Peripheral lymphadenopathy 9 33
Hepatomegaly 15 56
Splenomegaly 7 26
patient gastric cancer was suspected but no freeze microscopy
was done. The patient died before the result of the final
microscopic examination was available.
Laboratory data
Haemoglobin was below 10 g/100 ml in 15 (60% of evaluable
patients). Auto-immune haemolytic anaemia was the present-
ing feature in three patients. The white cell count was below
4 x 109 1-' in ten (43% of evaluable patients). The platelet
count was below 150 x 1091-' in ten (59% of evaluable
patients) and above 450 x 109 1` in three patients. Pancyto-
penia was noted in eight patients.
Bone marrow examination was performed in 12 patients at
a median of 20 days (range 6-118) before the time of death.
In five patients both aspirate and trephine biopsy was done.
The bone marrow study was suggestive of HD in three
patients, but no definite diagnosis was made. Myelofibrosis
was demonstrated in two patients. No signs of malignancy
were noted in the remaining bone marrow examinations.
Autopsy demonstrated bone marrow involvement in ten of
the 12 patients with a prior bone marrow examination.
Marked elevation of the erythrocyte sedimentation rate
(>50 mmh') was found in 14 of 22 patients.
Lactate dehydrogenase (LDH) was elevated in ten patients.
Alanine or aspartate aminotransferase were elevated in 11
patients; eight of these later showed hepatic involvement.
Bilirubin was elevated in six patients; five of these later
showed hepatic involvement. Serum copper was measured
only in one patient and found to be normal.
Radiology data
Chest X-ray was done in 26 patients, at a median of 10 days
(range 1-132) from last X-ray to death. Enlarged lymph
nodes in the mediastinum or pulmonary hilum were noted in
only two patients. However, involvement in the hilum or
mediastinum was found at autopsy in 15 of the 26 patients.
Pulmonary abnormalities suggestive of primary pulmonary
cancer or metastases were seen in three patients. CT-scan of
the thorax was performed in one patient and considered to
be without abnormalities. At autopsy in the same patient one
month later enlarged lymph nodes in the mediastinum were
disclosed.
Ultrasound of the abdomen was performed in five patients
at a median of 30 days (range 1-70) before death.
Hepatomegaly was noted in two and splenomegaly in one
patient. Enlarged lymph nodes were not seen on ultrasound
in any of the five patients, but all five patients had involve-
ment of the retroperitoneum at autopsy. Two of the five
patients were also examined with CT-scan of the abdomen 20
and 42 days before death respectively. In both patients
enlarged lymph nodes in the retroperitoneum were noted, but
biopsy was not performed.
Pathology data
Autopsy was performed in all patients but one. The diagnosis
in the later patient was based on the findings from a liver
biopsy obtained one day before death.
Histopathologic classification showed lymphocytic
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Figure 2 Age distribution of the 31 patients in whom Hodgkin's
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predominance in four patients, nodular sclerosis in one
patient, mixed cellularity in four patients, and lymphocytic
depletion in 12 patients. Six cases were unclassified. Review
of the histologic diagnoses was not achieved.
According to the Ann Arbor classification one patient had
stage I (the patient was admitted because of dyspnea, but
was dead on arrival at the hospital. Autopsy demonstrated
cervical HD compressing the larynx). The stages IIB, IIIB,
and IVA were found in one patient each. The remaining 23
patients were all classified as stage IVB.
Disease extent based on autopsy findings is shown in Table
II. The numbers must be considered as minimal figures since
in a considerable number of cases information from the
autopsy report was incomplete. This was especially true for
peripheral lymph nodes, bone marrow, and spleen for which
information was lacking in 12, seven and four cases respec-
tively. Involvement of extralymphatic sites outside bone mar-
row and liver occurred in 12 patients (44%).
Reasonsforfailure ofdiagnosis
After a thorough review of all case records, we have classified
the patients into five groups according to what we considered
to be the main reason why the correct diagnosis was not
established before death. The result is shown in Table III.
The median time span from first symptom to first consulta-
tion at a general practitioner could be evaluated in seven
patients and was 30 days (range 14-135). The median time
for the same patients from first consultation to admission in
hospital was 10 days (range 0-60). In 17 patients the median
time from first symptom to admission could be estimated and
was 55 days (range 2-150). The median time from admission
to death in the 27 patients was 31 days (range 0-450). Three
patients were admitted too terminally ill for diagnostic proce-
dures. About 1/3 of the patients showed symptoms which
were definitely suggestive of lymphoma, but the relevant
diagnostic procedures were not undertaken. It is especially
noteworthy that lymphadenopathy (peripheral or in the ret-
roperitoneum) was observed in nine patients without
attempts of biopsy. Patients without peripheral lym-
phadenopathy or visible abnormalities on chest X-ray, often
combined with falsely negative liver biopsy or bone marrow
examination, remained an enigma to the clinicians.
Most of the patients had no concurrent diseases. Two
patients were mentally handicapped, which in one case was
the reason for diagnostic passivity. Three patients were
alcoholics but active diagnostic procedures were performed in
all of them. Five patients had other severe somatic diseases;
apoplexia, diabetes mellitus with complications, adipositas,
chronic bronchitis, and arteriosclerosis. None of the patients
suffered from psychiatric disease. None of the patients were
reluctant to the proposed investigations.
Table II Localisation of HD as demonstrated at autopsy in 26 of
the 27 patients who died of unrecognised Hodgkin's disease
Number %
Peripheral lymph nodes 8 30








Soft tissue 2 7
Other sites (trachea, heart,
colon, pancreas, peritoneum, bone) 6 22
Discussion
In this unselected population based study we found that
unrecognised HD constituted 2.4% in patients less than 70
years of age, but the frequency increased significantly with
increasing age. The study by Nordentoft et al. comprising all
age groups in the same geographic area from 1971 to 1979
identified 16 patients (2.1%) at autopsy only (Nordentoft et
al., 1980). A remarkably high frequency was found in a study
from Stockholm in which unrecognised HD was found at
autopsy in 31 elderly patients who represented 12% of all
patients aged 15 years and more (Wedelin et al., 1984).
Most of the cases in our study occurred during the first
half of the study period. A possible explanation could be the
better access to CT-scan and ultrasound during recent years
which may facilitate a prompt diagnosis. However, the four
cases considered as coincidental findings all occurred in 1977
and 1978, and the frequency of HD found at autopsy during
an earlier period in the same area was lower (Nordentoft et
al., 1980). Therefore, another possible explanation of the
observed trend of a decreasing frequency of unrecognised
HD could be a falling autopsy rate (Cocchi et al., 1986;
Kristensen & Bille, 1989). It has previously been shown that
physicians are often unable to identify from the clinical data
autopsies likely to have a high diagnostic yield (Bekker &
Jensen, 1986; Landefeld et al., 1988), and the agreement
between the clinical and pathological diagnosis is lowest
among the oldest patients (Cocchi et al., 1986).
Pre-mortem biopsy was in three cases interpreted as car-
cinoma and in one case as chronic lymphadenitis. These
mistakes are presumably reduced with modern immunohis-
tologic methods.
Lymphocytic depletion (LD) is seen in 5% of unselected
Table III Reasons why the diagnosis of HD was not established before death, with
number of days from first admission to death
Patients Days
(n = 27) Median Range
I Patient admitted terminally ill 3 5 0-12
II Lack of essential investigations or unacceptable long
time spent waiting for examinations to be
performed, or for results of performed examination 10 33 4-450
III Diagnostic passivity because of the somatic
or mental condition of the patient 3 13 11-132
IV Diagnostic passivity because of wrongly
suspected somatic illnessa 6 56 9-120
V Diagnosis not obtained in spite of relevant
active approached 5 38 14-78
Note:
aTwo suspected of pulmonary cancer, one considered as progression of known CLL, one
with a lymph node biopsy suggestive of adenocarcinoma, and one considered to be primary
myelofibrosis. One case was considered as cholangitis.188 H. HASLE et al.
Danish patients (Nordentoft et al., 1980) but in the present
series LD represented 57% of all cases with a definite his-
tologic classification. LD is associated with higher age,
advanced stage, poor prognosis, and frequently occurs sub-
diaphragmatic without peripheral lymphadenopathy (Neiman
et al., 1973). The clinical features of LD frequently lead to
considerable difficulty in diagnosis (Neiman et al., 1973). The
histopathologic diagnosis of HD is recognised to be a
difficult area in pathology, especially regarding the distinction
of the LD subtype from non Hodgkin's lymphoma (NHL).
Reviews of cases of LD frequently result in reclassification to
other types of HD or to NHL (Kant et al., 1986). It is
possible that some of the cases in the present study represent
NHL, extending the problem to unrecognised lymphomas.
Fever was a prominent feature in the majority of the
patients. The definition of fever of unknown origin (FUO)
with a temperature above 38.3°C during a three week period
without any definite diagnosis after one week in hospital was
fulfilled by 14 patients (52%). In larger series of FUO a
neoplastic cause, most often lymphoma, was identified in
about 30% of the cases (Howard et al., 1977; Larson et al.,
1982). A neoplastic cause is most likely among patients
above 40 years of age (Deal, 1971).
Subdiaphragmatic disease occurred in all but four of the
patients in the present series and is often associated with
older age, advanced stage, and LD (Krikorian et al., 1986;
Villamor et al., 1991). Such patients frequently present with
systemic symptoms, e.g. FUO, without symptoms of an
abdominal mass (Krikorian et al., 1986). In such cases
abdominal ultrasound or CT-scan should be performed to
search for retroperitoneal masses. However, as shown in the
present study the retroperitoneum may be difficult to
visualise with ultrasound.
Hepatic involvement was a frequent finding in this series.
Liver involvement, often with a presumptive diagnosis of
primary liver disease, has also been prominent in other cases
of HD diagnosed post mortem (Lefkowitch et al., 1985,
Sobrinho-Simoes et al., 1983; Trewby et al., 1979). Hepatic
involvement is seen in only 6% of unselected patients with
HD (Nordentoft et al., 1980) but is frequently reported in
association with LD (Neiman et al., 1973). Liver biopsy was
not conclusive in four out of five cases in which it was
performed. However, granuloma formation was observed in
three patients which may be suggestive of HD (Brincker,
1986).
In the present series bone marrow involvement was dem-
onstrated in 48% in contrast with 5 to 15% in other series
(Jacquillat et al., 1981; Myers et al., 1974; O'Carroll et al.,
1976). Bone marrow involvement is often present in cases of
LD (Neiman et al., 1973). Of the patients with bone marrow
involvement 77% had a bone marrow examination per-
formed without establishment of the correct diagnosis. The
bone marrow biopsy from two patients demonstrated
myelofibrosis, a recognised presenting feature of HD
(Meadows et al., 1989). In some cases only aspirates were
performed which are usually insufficient for lymphoma diag-
nosis (Ferrant et al., 1975; Neiman et al., 1973).
We found a remarkably high frequency (44%) of involve-
ment of extralymphatic sites outside the bone marrow and
liver. This is unusual even in cases of LD with widespread
disease (Neiman et al., 1973). This uncommon feature of HD
may have contributed to the difficulty in diagnosis.
The 5 million inhabitants of Denmark are all covered by
the social security system and have free access to a general
practitioner and hospital treatment. Accordingly a delayed
diagnosis should not occur because of a lack of medical
services. However, three patients were admitted in hospital
too ill of their HD for diagnostic procedures. None of them
had sought medical advice before the day of admission.
In most patients the time span from first symptom or
admission to death was long enough to allow a number of
investigations to be performed. The frequent findings of
falsely negative chest X-ray, bone marrow examination, liver
biopsy, and ultrasound were misleading in many cases. In
about 1/3 of the cases clinical findings did not lead to
relevant diagnostic procedures (e.g. the lack of biopsy of
unexplained peripheral lymphadenopathy, search for lym-
phoma in cases of FUO).
Overall unrecognised HD represented only a minority of
all HD cases, but a significant number of older patients.
Most of the patients had a number of unfavourable prognos-
tic factors, but since most of them did not have any concur-
rent diseases they may have benifitted from a correct pre-
mortem diagnosis and a potentially curative treatment.
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